• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将气相色谱/质谱相对响应因子与分析物的物理化学和色谱性质相关联,以促进非靶向分析(NTA)中有机可提取物和可浸出物的定量分析。概念和经验考量。

Correlating GC/MS Relative Response Factors to Analyte's Physicochemical and Chromatographic Properties to Facilitate the Quantitation of Organic Extractables and Leachables in Non-Targeted Analysis (NTA). Concepts and Empirical Considerations.

作者信息

Jenke Dennis, Christiaens Piet, Verlinde Philippe, Baeten Jan, Beusen Jean-Marie

机构信息

Nelson Labs, Romeinsestraat 12, 3001 Heverlee, Belgium

Nelson Labs, Romeinsestraat 12, 3001 Heverlee, Belgium.

出版信息

PDA J Pharm Sci Technol. 2024 Dec 26;78(6):625-642. doi: 10.5731/pdajpst.2023.012884.

DOI:10.5731/pdajpst.2023.012884
PMID:39725482
Abstract

Leachables in drug products and from medical devices can adversely affect patient health and thus must be identified and quantified. Accurate and protective quantitation in target analysis for leachables (and extractables as potential leachables) is accomplished via compound-specific calibration curves. Quantification in non-targeted analysis (NTA) is complicated by the variable relative response factors (RRFs) among and between individual leachables and the circumstance that the leachables are not known until the NTA is completed. Protective quantitation in NTA is accomplished in various ways, depending on the identification status of the analyte. When an analyte's identity is confirmed, it is quantified using the compound's own RRF, obtained by analysis of a reference standard. In other identification circumstances, the concentration is calculated using a surrogate response, either linked to a surrogate compound or representative of a domain of leachables. Given the difficulty in matching an analyte with a proper surrogate, this article addresses quantitation via the latter approach. This article uses a database of >3000 GC/MS response factors to empirically divide the population of leachables into response factor domains, differentiated by either the analyte's polarity (log P) or retention time. Using the database, mean RRF values and uncertainty factors (UFs) are established for each domain and are used for quantitation. Protective quantitation is accomplished for nearly 84% of all leachables in the database (and presumably the entire population) by placing an analyte into its proper domain and then using the mean RRF divided by the UF for that domain as a universal response factor for all compounds in the domain.

摘要

药品和医疗器械中的可浸出物会对患者健康产生不利影响,因此必须对其进行识别和定量。通过化合物特异性校准曲线可实现对可浸出物(以及作为潜在可浸出物的提取物)目标分析中的准确和保护性定量。非靶向分析(NTA)中的定量则较为复杂,因为各个可浸出物之间以及不同可浸出物之间的相对响应因子(RRF)存在差异,而且在NTA完成之前可浸出物是未知的。NTA中的保护性定量可通过多种方式实现,具体取决于分析物的识别状态。当分析物的身份得到确认时,使用通过参考标准品分析获得的该化合物自身的RRF对其进行定量。在其他识别情况下,浓度通过替代响应来计算,该替代响应要么与替代化合物相关,要么代表可浸出物的一个域。鉴于将分析物与合适的替代物进行匹配存在困难,本文通过后一种方法探讨定量问题。本文使用一个包含>3000个气相色谱/质谱响应因子的数据库,根据分析物的极性(log P)或保留时间,凭经验将可浸出物群体划分为响应因子域。利用该数据库,为每个域建立平均RRF值和不确定因子(UFs),并将其用于定量。通过将分析物置于其合适的域中,然后使用该域的平均RRF除以UF作为该域中所有化合物的通用响应因子,可对数据库中近84%的所有可浸出物(大概也是整个群体)实现保护性定量。

相似文献

1
Correlating GC/MS Relative Response Factors to Analyte's Physicochemical and Chromatographic Properties to Facilitate the Quantitation of Organic Extractables and Leachables in Non-Targeted Analysis (NTA). Concepts and Empirical Considerations.将气相色谱/质谱相对响应因子与分析物的物理化学和色谱性质相关联,以促进非靶向分析(NTA)中有机可提取物和可浸出物的定量分析。概念和经验考量。
PDA J Pharm Sci Technol. 2024 Dec 26;78(6):625-642. doi: 10.5731/pdajpst.2023.012884.
2
Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 2-Errors of Inexact Identification and Inaccurate Quantitation.识别和减轻有机可提取物和浸出物筛查中的错误:第2部分——不精确识别和定量不准确的错误
PDA J Pharm Sci Technol. 2020 Jan-Feb;74(1):108-133. doi: 10.5731/pdajpst.2018.009779. Epub 2019 Jul 15.
3
Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.校正分析评估阈值 (AET) 和报告的可提取物浓度,以解决与色谱筛选提取物/浸出物相关的分析响应因子不确定性。
PDA J Pharm Sci Technol. 2020 May-Jun;74(3):348-358. doi: 10.5731/pdajpst.2019.010520. Epub 2020 Apr 15.
4
Is Retention Time and/or Structure Matching a Solution to the Challenge of Providing Quantitative Data When Screening for Extractables and Leachables by GC/MS?保留时间和/或结构匹配是否是在通过 GC/MS 筛选提取和浸出物时提供定量数据所面临挑战的解决方案?
PDA J Pharm Sci Technol. 2022 May-Jun;76(3):236-247. doi: 10.5731/pdajpst.2021.012673. Epub 2021 Nov 15.
5
Identification and quantification of medical device extractables and leachables via non-target analysis (NTA); Analytical uncertainty.通过非靶向分析(NTA)鉴定和量化医疗器械浸出物和可提取物;分析不确定度。
J Pharm Biomed Anal. 2024 Apr 15;241:115985. doi: 10.1016/j.jpba.2024.115985. Epub 2024 Jan 19.
6
Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.采用多检测器方法减少提取和浸出物(E&L)分析中的相对响应因子变化,以减少不确定性因素的需要。
J Pharm Biomed Anal. 2020 Jul 15;186:113334. doi: 10.1016/j.jpba.2020.113334. Epub 2020 May 1.
7
Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.通过管理结果实现有机可提取物和可沥滤物色谱筛选方法的标准化。
PDA J Pharm Sci Technol. 2023 Jul-Aug;77(4):329-338. doi: 10.5731/pdajpst.2021.012671. Epub 2023 Mar 31.
8
Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.识别和减轻有机浸出物和可提取物筛选中的错误:第 1 部分-色谱筛选有机浸出物和可提取物中的错误简介以及对遗漏错误的讨论。
PDA J Pharm Sci Technol. 2020 Jan-Feb;74(1):90-107. doi: 10.5731/pdajpst.2018.009761. Epub 2019 Jun 17.
9
A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.一份与药品包装、给药、管理及生产系统中所用材料相关的可提取物安全性影响信息汇编。
PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):407-55. doi: 10.5731/pdajpst.2014.00995.
10
Establishment of a reference standard database for use in the qualitative and semi-quantitative analysis of pharmaceutical contact materials within an extractables survey by GC-MS.建立参考标准数据库,用于通过 GC-MS 进行提取调查中药物接触材料的定性和半定量分析。
J Pharm Biomed Anal. 2018 Mar 20;151:49-60. doi: 10.1016/j.jpba.2017.12.054. Epub 2017 Dec 29.

引用本文的文献

1
Examining structure-based surrogate selection for quantitative non-targeted analysis.基于结构的替代物选择用于定量非靶向分析的研究
Anal Bioanal Chem. 2025 Jun 9. doi: 10.1007/s00216-025-05919-8.
2
Practical Considerations of FDA's CLAP List to Support Testing of Extractables for Pharmaceuticals and Medical Devices.美国食品药品监督管理局(FDA)《可提取物清单》(CLAP)对支持药品和医疗器械可提取物测试的实际考量
ACS Omega. 2025 May 14;10(20):20801-20816. doi: 10.1021/acsomega.5c01982. eCollection 2025 May 27.